When medicines are made outside the factory: Why pharmacovigilance matters more than ever
A high-profile court case involving a South African compounding pharmacy has highlighted the critical importance of pharmacovigilance. Experts argue that monitoring medicine safety after it reaches the public is essential, as clinical trials cannot predict every rare adverse reaction.
Facebook 0 Tweet 0 Email 0 A high-profile court case has thrust the legalities of compounding medicines in South Africa into the spotlight. Behind the immediate legal issues hide a series of unresolved questions about how we should ensure that compounded medicines used in South Africa are safe, argue Professor Renier Coetzee and Lara van Niekerk.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in